Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron
Cele, S.; Bernstein, M.; Karim, F.; Khan, K.; Ganga, Y.; Jule, Z.; Reedoy, K.; Lustig, G.; Samsunder, N.; Mazibuko, M.; Hwa, S.-H.; Manickchund, N.; Magula, N.; Lessells, R.; de Oliveira, T.; Karim, S. A.; Hanekom, W.; COMMIT-KZN Team, ; Gosnell, B.; Moosa, Y.; Sigal, A.
Show abstract
Omicron (B.1.1.529) shows extensive escape from vaccine immunity, although vaccination reduces severe disease and death1. Boosting with vaccines incorporating variant spike sequences could possibly broaden immunity2. One approach to choose the variant may be to measure immunity elicited by vaccination combined with variant infection. Here we investigated Omicron neutralization in people infected with the Beta (B.1.351) variant and subsequently vaccinated with Pfizer BNT162b2. We observed that Beta infection alone elicited poor Omicron cross-neutralization, similar to what we previously found3 with BNT162b2 vaccination alone or in combination with ancestral or Delta virus infection. In contrast, Beta infection combined with BNT162b2 vaccination elicited neutralization with substantially lower Omicron escape.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies 95%
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals 95%
- High number of SARS-CoV-2 persistent infections uncovered through genetic analysis of samples from a large community-based surveillance study 94%
Similar papers in this journal
- The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism 95%
- Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections 94%
- Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.